Janus Henderson Group PLC Horizon Therapeutics Public LTD CO Transaction History

Janus Henderson Group PLC

$178 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $3.22 Million - $3.76 Million	32,517 Added 31.85%	134,617 $15.6 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $158 Million - $184 Million	-1,636,046 Reduced 94.13%	102,100 $10.5 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $237 Million - $251 Million	-2,211,373 Reduced 55.99%	1,738,146 $190 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $130 Million - $238 Million	-2,087,499 Reduced 34.58%	3,949,519 $449 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $82.5 Million - $119 Million	-1,399,592 Reduced 18.82%	6,037,018 $374 Million

Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $21.4 Million - $31.3 Million	268,993 Added 3.75%	7,436,610 $593 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $9.98 Million - $12.7 Million	115,429 Added 1.64%	7,167,617 $754 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $98.4 Million - $120 Million	998,456 Added 16.49%	7,052,188 $760 Million
Q3 2021 Nov 16, 2021	BUY	$91.91 - $110.37 $21.1 Million - $25.3 Million	229,538 Added 3.94%	6,053,732 $663 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $153 Million - $170 Million	-1,772,963 Reduced 23.34%	5,824,194 $545 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $42.8 Million - $56.9 Million	-595,464 Reduced 7.27%	7,597,157 $699 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $50 Million - $62.9 Million	-745,532 Reduced 8.34%	8,192,621 $599 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $32.1 Million - $46.4 Million	580,629 Added 6.95%	8,938,153 $694 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $50.6 Million - $95.4 Million	1,674,602 Added 25.06%	8,357,524 $465 Million
Q1 2020 May 14, 2020	BUY	$24.87 - $38.56 $20.1 Million - $31.1 Million	807,303 Added 13.74%	6,682,922 $198 Million
Q4 2019 Feb 18, 2020	BUY	$25.43 - $36.67 $149 Million - $215 Million	5,875,619 New	5,875,619 $213 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account